Clinical trials
Not yet recruiting Phase 1/2 Multiple Myeloma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shenzhen Geno-Immune Medical Institute | 2 |
| Biotroy Therapeutics | 1 |
| CARsgen Therapeutics Co., Ltd. | 1 |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| Dana-Farber Cancer Institute | 1 |
| Fuling Zhou | 1 |
| Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 1 |
| Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 1 |
| Hebei Senlang Biotechnology Inc., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 16 |
| Recurrence | 3 |
| Hematologic Neoplasms | 2 |
| Lymphoma | 2 |
| Neoplasms | 2 |
| Neoplasms, Plasma Cell | 2 |
| Plasmacytoma | 2 |
| Blood Protein Disorders | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Hepatocellular | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.